Hangzhou Coco Healthcare Products Co.Ltd.

SHE:301009 China Household & Personal Products
Market Cap
$442.77 Million
CN¥3.25 Billion CNY
Market Cap Rank
#16711 Global
#4414 in China
Share Price
CN¥11.95
Change (1 day)
-1.73%
52-Week Range
CN¥9.17 - CN¥16.98
All Time High
CN¥34.15
About

Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, famil… Read more

Hangzhou Coco Healthcare Products Co.Ltd. (301009) - Net Assets

Latest net assets as of September 2025: CN¥1.41 Billion CNY

Based on the latest financial reports, Hangzhou Coco Healthcare Products Co.Ltd. (301009) has net assets worth CN¥1.41 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.15 Billion) and total liabilities (CN¥739.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥1.41 Billion
% of Total Assets 65.63%
Annual Growth Rate 16.92%
5-Year Change 107.1%
10-Year Change N/A
Growth Volatility 44.25

Hangzhou Coco Healthcare Products Co.Ltd. - Net Assets Trend (2017–2024)

This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)

The table below shows the annual net assets of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024.

Year Net Assets Change
2024-12-31 CN¥1.41 Billion -2.63%
2023-12-31 CN¥1.45 Billion +1.25%
2022-12-31 CN¥1.43 Billion -5.00%
2021-12-31 CN¥1.51 Billion +121.12%
2020-12-31 CN¥681.55 Million +48.79%
2019-12-31 CN¥458.05 Million -14.49%
2018-12-31 CN¥535.64 Million +13.35%
2017-12-31 CN¥472.55 Million --

Equity Component Analysis

This analysis shows how different components contribute to Hangzhou Coco Healthcare Products Co.Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 67.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥306.85 Million 23.00%
Common Stock CN¥271.86 Million 20.38%
Other Comprehensive Income CN¥81.82 Million 6.13%
Other Components CN¥673.55 Million 50.49%
Total Equity CN¥1.33 Billion 100.00%

Hangzhou Coco Healthcare Products Co.Ltd. Competitors by Market Cap

The table below lists competitors of Hangzhou Coco Healthcare Products Co.Ltd. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hangzhou Coco Healthcare Products Co.Ltd.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,372,736,913 to 1,334,074,525, a change of -38,662,388 (-2.8%).
  • Net income of 31,172,830 contributed positively to equity growth.
  • Dividend payments of 20,138,587 reduced retained earnings.
  • Share repurchases of 49,693,884 reduced equity.
  • Other comprehensive income increased equity by 4,618,297.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥31.17 Million +2.34%
Dividends Paid CN¥20.14 Million -1.51%
Share Repurchases CN¥49.69 Million -3.72%
Other Comprehensive Income CN¥4.62 Million +0.35%
Other Changes CN¥-4.62 Million -0.35%
Total Change CN¥- -2.82%

Book Value vs Market Value Analysis

This analysis compares Hangzhou Coco Healthcare Products Co.Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.33x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 5.53x to 2.33x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 CN¥2.16 CN¥11.95 x
2018-12-31 CN¥2.43 CN¥11.95 x
2019-12-31 CN¥1.47 CN¥11.95 x
2020-12-31 CN¥3.03 CN¥11.95 x
2021-12-31 CN¥5.20 CN¥11.95 x
2022-12-31 CN¥4.98 CN¥11.95 x
2023-12-31 CN¥4.76 CN¥11.95 x
2024-12-31 CN¥5.14 CN¥11.95 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hangzhou Coco Healthcare Products Co.Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 2.34%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.89%
  • • Asset Turnover: 0.52x
  • • Equity Multiplier: 1.57x
  • Recent ROE (2.34%) is below the historical average (10.29%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 9.71% 5.32% 0.82x 2.22x CN¥-1.24 Million
2018 12.36% 6.59% 0.91x 2.06x CN¥11.40 Million
2019 21.92% 7.45% 1.09x 2.69x CN¥47.55 Million
2020 34.89% 13.09% 1.09x 2.44x CN¥152.67 Million
2021 2.81% 3.35% 0.57x 1.47x CN¥-101.73 Million
2022 -3.19% -3.64% 0.61x 1.44x CN¥-178.38 Million
2023 1.47% 1.87% 0.54x 1.45x CN¥-117.09 Million
2024 2.34% 2.89% 0.52x 1.57x CN¥-102.23 Million

Industry Comparison

This section compares Hangzhou Coco Healthcare Products Co.Ltd.'s net assets metrics with peer companies in the Household & Personal Products industry.

Industry Context

  • Industry: Household & Personal Products
  • Average net assets among peers: $1,143,263,014
  • Average return on equity (ROE) among peers: 10.42%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Hangzhou Coco Healthcare Products Co.Ltd. (301009) CN¥1.41 Billion 9.71% 0.52x $141.71 Million
Lonkey Industrial Co Ltd Guangzhou (000523) $104.40 Million 15.81% 1.73x $544.84 Million
Tianjin Yiyi Hygiene Products Co Ltd (001206) $1.73 Billion 6.61% 0.14x $227.82 Million
Hunan Resun Co Ltd (001218) $905.44 Million 24.55% 0.67x $278.75 Million
Dencare (Chongqing) Oral Care Co. Ltd. A (001328) $542.28 Million 24.82% 0.88x $209.36 Million
Qingdao Kingking Applied Chemistry Co Ltd (002094) $1.92 Billion 9.63% 0.50x $502.87 Million
C&S Paper Co Ltd (002511) $2.28 Billion 5.08% 0.97x $746.47 Million
Anhui Deli Household Glass Co Ltd (002571) $1.41 Billion -9.08% 0.25x $335.13 Million
Mingchen Health Co Ltd Class A (002919) $739.25 Million 3.43% 0.68x $467.92 Million
Chongqing Baiya Sanitary Products Co (003006) $359.21 Million 16.81% 0.32x $504.23 Million
Chengdu Rainbow Appliance Gr (003023) $1.44 Billion 6.57% 0.37x $163.63 Million